CASK Human shRNA Plasmid Kit (Locus ID 8573)
CAT#: TF320586
CASK - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | CASK Human shRNA Plasmid Kit (Locus ID 8573) |
Locus ID | 8573 |
UniProt ID | O14936 |
Synonyms | CAGH39; CAMGUK; CMG; FGS4; hCASK; LIN2; MICPCH; MRXSNA; TNRC8 |
Vector | pRFP-C-RS |
Format | Retroviral plasmids |
Kit Components | CASK - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector(Gene ID = 8573). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRFP-C-RS Vector, TR30015, included for free. |
RefSeq | NM_001126054, NM_001126055, NM_003688, NM_003688.1, NM_003688.2, NM_003688.3, NM_001126055.1, NM_001126055.2, NM_001126054.1, NM_001126054.2, BC117311, BC029936, BC035990, BC143454, BC143456, NM_001367721 |
Summary | This gene encodes a calcium/calmodulin-dependent serine protein kinase. The encoded protein is a MAGUK (membrane-associated guanylate kinase) protein family member. These proteins are scaffold proteins and the encoded protein is located at synapses in the brain. Mutations in this gene are associated with FG syndrome 4, intellectual disability and microcephaly with pontine and cerebellar hypoplasia, and a form of X-linked intellectual disability. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Lateral Membrane-Specific MAGUK CASK Down-Regulates NaV1.5 Channel in Cardiac Myocytes
,Eichel, CA;Beuriot, A;Chevalier, MY;Rougier, JS;Louault, F;Dilanian, G;Amour, J;Coulombe, A;Abriel, H;Hatem, SN;Balse, E;,
Circ. Res.
,PubMed ID 27364017
[CASK]
|
Organisation et régulation des canaux sodiques et potassiques cardiaques par les protéines MAGUK
,Eichel, C;,
Thesis
[CASK]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...